L3VLUP
ProSign in

MTD · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

MTDJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • MTD
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterMTDJNJ
Q3 202018 holders, $3.5bn30 holders, $26.2bn
Q4 202016 holders, $3.7bn32 holders, $26.6bn
Q1 202119 holders, $3.3bn31 holders, $25.3bn
Q2 202123 holders, $3.8bn37 holders, $25.6bn
Q3 202120 holders, $3.5bn40 holders, $24.1bn
Q4 202118 holders, $4.4bn33 holders, $25.2bn
Q1 202220 holders, $3.5bn35 holders, $28.2bn
Q2 202220 holders, $2.9bn33 holders, $26.9bn
Q3 202219 holders, $2.7bn36 holders, $25.4bn
Q4 202217 holders, $3.8bn35 holders, $27.6bn
Q1 202324 holders, $4.2bn42 holders, $24.5bn
Q2 202325 holders, $3.4bn38 holders, $25.0bn
Q3 202323 holders, $1.7bn37 holders, $18.9bn
Q4 202324 holders, $2.0bn31 holders, $19.0bn
Q1 202420 holders, $2.0bn32 holders, $19.7bn
Q2 202417 holders, $2.4bn35 holders, $20.4bn
Q3 202417 holders, $2.6bn28 holders, $22.3bn
Q4 202417 holders, $1.9bn37 holders, $20.4bn
Q1 202515 holders, $2.0bn32 holders, $20.5bn
Q2 202512 holders, $2.0bn31 holders, $18.4bn
Q3 202511 holders, $2.0bn32 holders, $23.7bn
Q4 202514 holders, $2.5bn29 holders, $27.8bn
Q1 202610 holders, $2.4bn34 holders, $35.6bn
Q2 202614 holders, $3.0bn33 holders, $39.1bn
MTD

Mettler Toledo International

Holders
24
Reported value
$2.0bn
Buyers
15
Sellers
10

Breadth +5 among 93 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
31
Reported value
$19.0bn
Buyers
16
Sellers
16

Breadth 0 among 93 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q4 2023

Among the 42 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only MTD (11)

Arrowstreet Capital LP, Artisan Partners LP, Baillie Gifford & Co, Holocene Advisors LP, Marshall Wace LLP, Maverick Capital Ltd, Millennium Management LLC, PDT Partners LLC, Point72 Asset Management LP, Schonfeld Strategic Advisors LLC, Scion Asset Management LLC

Only JNJ (18)

Bridgewater Associates LP, D. E. Shaw & Co., Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Markel Group Inc, MFS Investment Management, Neuberger Berman Group LLC, Quantbot Technologies LP, Susquehanna International Group LLP, T. Rowe Price Associates Inc, Verition Fund Management LLC, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →